乱世加人 – Page 67

01/21/202101/21/2021

Sanctioned

China has decided to sanction 28 persons who have seriously violated China’s sovereignty and who have been mainly responsible for such U.S. moves on China-related issues. They include Michael R. Pompeo, Peter K. Navarro, Robert C. O’Brien, David R. Stilwell, Matthew Pottinger, Alex M. Azar II, Keith J. Krach, and Kelly D. K. Craft of the Trump administration as well as John R. Bolton and Stephen K. Bannon. These individuals and their immediate family members are prohibited from entering the mainland, Hong Kong and Macao of China. They and companies and institutions associated with them are also restricted from doing business with China.

01/21/2021

China’s FDI up 6.2% to record high in 2020

China poised to take over the US as the world’s top destinations for foreign investment in 2020. This is helped by the country’s ability to secure a stable production while the global supply chain is fractured by the coronavirus outbreak.

01/20/202103/04/2021

Day Hike to Nei Lak Shan (Ngong Ping) 1-20-21

*彌勒山* +751m 香港第八高的山峰，其名稱源自「彌勒菩薩」。山上建有氣象監察站及警務署的轉發站。

Wisdom Path is a landscaped installation of wooden columns inscribed with the calligraphy of the complete verses of the Heart Sutra written by master Sinologist Professor Jao Tsung-I.

心经简林位处大屿山凤凰山山麓，是国学大师饶宗颐教授的心经墨宝，整篇书法都刻在园林的木柱上，因形似古时的竹简，因此名为「心经简林」。

《心经》的梵文全名是《般若波罗蜜多心经》，是梵文里面智慧和圆满的象徵，刻在心经简林的经文是唐朝玄奘法师的译本，也是儒、释、道三教所共尊的宝典。这个户外木柱群由38条长8米至10米、宽1米多的梨花木木柱组成，依照天然山势排列成无限符号 (∞)，代表生生不息。木柱群的最高点是编号23的木柱，这里刻意留白，以象徵《心经》「空」的要义。饶宗颐教授指出《心经》最深沉的意蕴就是在于「无罣碍」。

01/20/202101/21/2021

The Clown in exile

No need to kick a dead dog.

01/20/202101/20/2021

Tiantong 1-03

1-20-21 China successfully conducted the year’s first space launch from
Xichang Satellite Launch Center in SW China’s Sichuan,
The satellite Tiantong 1-03 was launched at by Long March-3B carrier rocket and entered planned orbit successfully.

Image may contain: sky, night, cloud, fire, twilight, basketball court, skyscraper, tree and outdoor

01/19/202101/19/2021

Gene-editing therapy clinical trial

1-19-21 China’s drug authority approved China’s first gene-editing therapy clinical trial . The approved gene-editing product et-01 , developed by Edigene Inc. 博雅辑因(北京)科技有限公司 , a Zhongguancun biomedical enterprise in Beijing, was for blood transfusion dependent β – thalassemia 地中海型贫血.
这种技术叫做：β地中海贫血的基因组编辑治疗。它运用基因组编辑技术，对病人的造血干细胞重新编辑，从而改进造血功能。这项治疗技术目前在世界上只有极少企业在做，而中国仅此一家。

01/19/2021

100 tln yuan

China’s GDP topped 100 tln yuan for first time, reaching 101.59 tln yuan with 2.3% y-o-y expansion in 2020, said NBS official on Mon. It is estimated to account for 17% of global total for the year, with China expected to become only major economy with positive growth in 2020.